Regional collaborations emerge to address the biomanufacturing workforce crisis

In Philadelphia alone, cell and gene therapy and gene editing companies are preparing to add more than 1,100 new employees per year for the next decade, a net gain of more than 6,000 new workers.

Companies in Philadelphia are working hard to get ahead of this pending and existing issue. They have established the Life Science Talent Pipeline Collaborative as an employer-led organization guided by and for employers to grow the workforce. Participating employers and institutions include the University of Pennsylvania, Children’s Hospital, and Penn spinouts: Amicus Therapeutics, Cabaletta Bio, Carisma Therapeutics, Passage Bio and Spark Therapeutics.

Read More in BioBuzz

Skip to content